ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0188

Investigating Canadians’ information needs related to lupus: A Google Trends analysis of online search query data

Taylor Williamson1, Emily Shantz1, Susan Elliott1, Christine Sperling2, Karen H. Costenbader3 and May Choi4, 1University of Waterloo, Waterloo, Canada, 2None, Calgary, Canada, 3Harvard Medical School and Brigham and Women's Hospital, Boston, MA, 4University of Calgary, Calgary, AB, Canada

Meeting: ACR Convergence 2025

Keywords: Education, education, medical, education, patient, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0175–0198) Health Services Research Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: A lack of knowledge surrounding SLE has been identified as a main challenge for patients, particularly those seeking a diagnosis or recently diagnosed. Subsequently, many turn to online sources for information, where they risk encountering misleading or even endangering mis- or disinformation. Hence, we investigated the public awareness of SLE and how this varies spatially across Canada using health geographical approaches to examine Google Trends (GT) data, a tool for assessing public knowledge and information.

Methods: This research employs a health geographical approach to exploring spatial and temporal trends in information-seeking behaviours and associated knowledge gaps related to SLE in Canada. Using GT, relative search volumes (RV), associated topics and queries were collected from 2004-2024, using keywords for “lupus” (Fig1). The top 25 search terms were collected from each province and territory, and these search terms were analyzed thematically. The research process leveraged an integrated knowledge translation approach, in which a patient partner living with SLE was a key part of the research team.

Results: Search volumes for the search term “lupus” in Canada hit an all-time peak in October 2015 (RV=1.0) (Fig2,Table). This peak occurred in all provinces simultaneously, correlating with celebrity Selena Gomez’s SLE diagnosis. Additional peaks were observed across Canada in July 2009 (RV=0.58), September 2016 (RV=0.69), and September 2017 (RV=0.78), all of which were correlated with milestones in the development and eventual approval of belimumab for SLE. Similarly, a peak in August 2016 (RV=0.66) was associated with positive Phase II trials for voclosporin. A national peak in June 2010 (RV=0.60) was associated with the 9th International Congress on SLE held in Vancouver, Canada. There was a marked trough across all Canadian provinces in November and December 2020 (RV=0.28), perhaps reflecting that SLE-related concerns were overshadowed by the ongoing COVID-19 pandemic. Overall, interest was highest in Newfoundland (RV=1.0), New Brunswick (RV=0.83), and Manitoba (RV=0.80), though the top related topics and queries varied spatially among provinces. The most frequently searched terms typically fell within the following themes: causes of lupus, diagnosis, symptoms, medication, and treatment. Some search terms were spatially unique, only appearing in one province, including search terms in French (“lupus maladie”, Quebec), and Indonesian (“penyakit lupus”, Newfoundland) languages.

Conclusion: An understanding of the information needs of the general public related to SLE, and how they vary spatially, is critical for designing and implementing targeted and effective patient education interventions. To this end, these research results will be shared and triangulated with the knowledge needs of advocacy organizations and the realities of lived SLE experience, through a deliberative dialogue with key stakeholders from across Canada. This research and deliberative dialogue will set a foundation for the design and implementation of relevant interventions to effectively reduce SLE-related health disparities and improve SLE-related quality of life nationwide.

Supporting image 1Figure 1. Google Trends dashboard displaying 1.0) search interest over time and 1.1) regional distribution across Canada

Supporting image 2Figure 2. Relative Volume (RV) for the search term “lupus” across Canada (2004-2024)

Supporting image 3Table. Timeline, Key Events & Major Peaks, Search for “Lupus” (Canada 2004–2024)


Disclosures: T. Williamson: None; E. Shantz: None; S. Elliott: None; C. Sperling: None; K. Costenbader: AbbVie, 2, 5, Bain, 2, 5, Biogen, 2, 5, Brigham & Women’s Hospital, 3, GSK, 2, 5; M. Choi: AstraZeneca, 2, 5, 6, Celltrion, 2, MitogenDx, 2, Organon, 6, Werfen, 2.

To cite this abstract in AMA style:

Williamson T, Shantz E, Elliott S, Sperling C, Costenbader K, Choi M. Investigating Canadians’ information needs related to lupus: A Google Trends analysis of online search query data [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/investigating-canadians-information-needs-related-to-lupus-a-google-trends-analysis-of-online-search-query-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/investigating-canadians-information-needs-related-to-lupus-a-google-trends-analysis-of-online-search-query-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology